DLG4-related synaptopathy: a new rare brain disorder.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
05 2021
Historique:
received: 16 10 2020
accepted: 15 12 2020
revised: 12 12 2020
pubmed: 19 2 2021
medline: 4 6 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

Postsynaptic density protein-95 (PSD-95), encoded by DLG4, regulates excitatory synaptic function in the brain. Here we present the clinical and genetic features of 53 patients (42 previously unpublished) with DLG4 variants. The clinical and genetic information were collected through GeneMatcher collaboration. All the individuals were investigated by local clinicians and the gene variants were identified by clinical exome/genome sequencing. The clinical picture was predominated by early onset global developmental delay, intellectual disability, autism spectrum disorder, and attention deficit-hyperactivity disorder, all of which point to a brain disorder. Marfanoid habitus, which was previously suggested to be a characteristic feature of DLG4-related phenotypes, was found in only nine individuals and despite some overlapping features, a distinct facial dysmorphism could not be established. Of the 45 different DLG4 variants, 39 were predicted to lead to loss of protein function and the majority occurred de novo (four with unknown origin). The six missense variants identified were suggested to lead to structural or functional changes by protein modeling studies. The present study shows that clinical manifestations associated with DLG4 overlap with those found in other neurodevelopmental disorders of synaptic dysfunction; thus, we designate this group of disorders as DLG4-related synaptopathy.

Identifiants

pubmed: 33597769
doi: 10.1038/s41436-020-01075-9
pii: S1098-3600(21)01446-5
doi:

Substances chimiques

DLG4 protein, human 0
Disks Large Homolog 4 Protein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

888-899

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States

Références

Sheng, M. & Kim, E. The postsynaptic organization of synapses. Cold Spring Harb. Perspect. Biol. 3, a005678 (2011).
doi: 10.1101/cshperspect.a005678
Nithianantharajah, J. et al. Synaptic scaffold evolution generated components of vertebrate cognitive complexity. Nat. Neurosci. 16, 16–24 (2013).
doi: 10.1038/nn.3276
Philips, A. K. et al. X-exome sequencing in Finnish families with Intellectual Disability - Four novel mutations and two novel syndromic phenotypes. Orphanet J. Rare Dis. 9, 49 (2014).
doi: 10.1186/1750-1172-9-49
Tarpey, P. et al. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 75, 318–324 (2004).
doi: 10.1086/422703
Guo, H. et al. Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Mol. Autism 9, 64 (2018).
doi: 10.1186/s13229-018-0247-z
Xu, B., Roos, J. L., Levy, S., Van Rensburg, E. J., Gogos, J. A. & Karayiorgou, M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40, 880–885 (2008).
doi: 10.1038/ng.162
Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142–153 (2012).
doi: 10.1038/mp.2011.154
Feyder, M. et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams’ syndrome. Am. J. Psychiatry 167, 1508–1517 (2010).
doi: 10.1176/appi.ajp.2010.10040484
Coley, A. A. & Gao, W. J. PSD-95 deficiency disrupts PFC-associated function and behavior during neurodevelopment. Sci. Rep. 9, 9486 (2019).
doi: 10.1038/s41598-019-45971-w
Winkler, D. et al. Hypersocial behavior and biological redundancy in mice with reduced expression of PSD95 or PSD93. Behav. Brain Res. 352, 35–45 (2018).
doi: 10.1016/j.bbr.2017.02.011
Rauch, A. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet. 380, 1674–1682 (2012).
doi: 10.1016/S0140-6736(12)61480-9
Lelieveld, S. H. et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat. Neurosci. 19, 1194–1196 (2016).
doi: 10.1038/nn.4352
Fitzgerald, T. W. et al. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 519, 223–228 (2015).
doi: 10.1038/nature14135
Bosch, D. G. M. et al. Novel genetic causes for cerebral visual impairment. Eur. J. Hum. Genet. 24, 660–665 (2016).
doi: 10.1038/ejhg.2015.186
Xing, J. et al. Resequencing and association analysis of Six PSD-95-related genes as possible susceptibility genes for schizophrenia and autism spectrum disorders. Sci. Rep. 6, 27491 (2016).
doi: 10.1038/srep27491
Moutton, S. et al. Truncating variants of the DLG4 gene are responsible for intellectual disability with marfanoid features. Clin. Genet. 93, 1172–1178 (2018).
Baker, S. W. et al. Automated clinical exome reanalysis reveals novel diagnoses. J. Mol. Diagn. 21, 38–48 (2019).
doi: 10.1016/j.jmoldx.2018.07.008
Sobreira, N., Schiettecatte, F., Valle, D. & Hamosh, A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 36, 928–930 (2015).
doi: 10.1002/humu.22844
Firth, H. V. et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 84, 524–533 (2009).
doi: 10.1016/j.ajhg.2009.03.010
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17, 405–424 (2015).
doi: 10.1038/gim.2015.30
Amendola, L. M. et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. Am. J. Hum. Genet. 98, 1067–1076 (2016).
doi: 10.1016/j.ajhg.2016.03.024
Coban-Akdemir, Z. et al. Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles. Am. J. Hum. Genet. 103, 171–178 (2018).
doi: 10.1016/j.ajhg.2018.06.009
Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell. 176, 535–548 (2019).
doi: 10.1016/j.cell.2018.12.015
McGee, A. W., Dakoji, S. R., Olsen, O., Bredt, D. S., Lim, W. A. & Prehoda, K. E. Structure of the SH3-guanylate kinase module from PSD-95 suggests a mechanism for regulated assembly of MAGUK scaffolding proteins. Mol. Cell 8, 1291–1301 (2001).
doi: 10.1016/S1097-2765(01)00411-7
Fomina, S. et al. Self-directed assembly and clustering of the cytoplasmic domains of inwardly rectifying Kir2.1 potassium channels on association with PSD-95. Biochim. Biophys. Acta 1808, 2374–2389 (2011).
doi: 10.1016/j.bbamem.2011.06.021
Benkert, P., Biasini, M. & Schwede, T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 27, 343–350 (2011).
doi: 10.1093/bioinformatics/btq662
Krab, L. C. et al. Delineation of phenotypes and genotypes related to cohesin structural protein RAD21. Hum. Genet. 139, 575–592 (2020).
doi: 10.1007/s00439-020-02138-2
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V. & Skrzypek, E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 (2015).
doi: 10.1093/nar/gku1267
Grant, S. G. N. Synapse diversity and synaptome architecture in human genetic disorders. Hum. Mol. Genet. 28, R219–R225 (2019).
doi: 10.1093/hmg/ddz178
Tristán-Noguero, A. & García-Cazorla, À. Synaptic metabolism: a new approach to inborn errors of neurotransmission. J. Inherit. Metab. Dis. 41, 1065–1075 (2018).
doi: 10.1007/s10545-018-0235-7
Zapata, J. et al. Epilepsy and intellectual disability linked protein Shrm4 interaction with GABA B Rs shapes inhibitory neurotransmission. Nat. Commun. 8, 14536 (2017).
doi: 10.1038/ncomms14536
Ung, D. C. et al. Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse. Mol. Psychiatry 23, 1356–1367 (2017).
doi: 10.1038/mp.2017.39
Abela, L. & Kurian, M. A. Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms. J. Inherit. Metab. Dis. 41, 1077–1091 (2018).
doi: 10.1007/s10545-018-0205-0
Jang, M. et al. Coexistence of glutamatergic spine synapses and shaft synapses in substantia nigra dopamine neurons. Sci. Rep. 5, 14773 (2015).
doi: 10.1038/srep14773
Morigaki, R. & Goto, S. Postsynaptic density protein 95 in the striosome and matrix compartments of the human neostriatum. Front. Neuroanat. 9, 154 (2015).
doi: 10.3389/fnana.2015.00154
Gamss, R. P., Slasky, S. E., Bello, J. A., Miller, T. S. & Shinnar, S. Prevalence of hippocampal malrotation in a population without seizures. Am. J. Neuroradiol. 30, 1571–1573 (2009).
doi: 10.3174/ajnr.A1657
Chan, S. et al. Hippocampal malrotation is associated with prolonged febrile seizures: Results of the FEBSTAT study. Am. J. Roentgenol. 205, 1068–1074 (2015).
doi: 10.2214/AJR.14.13330
Krishnan, M. L. et al. Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infant. Nat. Commun. 8, 428 (2017).
doi: 10.1038/s41467-017-00422-w
Ohnuma, T., Kato, H., Arai, H., Faull, R. L. M., McKenna, P. J. & Emson, P. C. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport. 11, 3133–3137 (2000).
doi: 10.1097/00001756-200009280-00019
Kaplanis, J. et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature 586, 757–762 (2020).
doi: 10.1038/s41586-020-2832-5

Auteurs

Agustí Rodríguez-Palmero (A)

Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, and Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.
Paediatric Neurology Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.

Melissa Maria Boerrigter (MM)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

David Gómez-Andrés (D)

Child Neurology Unit. Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Kimberly A Aldinger (KA)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Íñigo Marcos-Alcalde (Í)

Molecular Modelling Group, Severo Ochoa Molecular Biology Centre (CBM SO, CSIC-UAM), Madrid, Spain.
Bioscience Research Institute, School of Experimental Sciences, Francisco de Vitoria University, Pozuelo de Alarcón, Spain.

Bernt Popp (B)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Institute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig, Germany.

David B Everman (DB)

Greenwood Genetic Center, Greenwood, SC, USA.

Alysia Kern Lovgren (AK)

Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Stephanie Arpin (S)

Service de génétique, CHU de Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Vahid Bahrambeigi (V)

Greenwood Genetic Center, Greenwood, SC, USA.
Graduate School of Biomedical Sciences, The University of Texas, MD Anderson Cancer Center UTHealth, Houston, TX, USA.

Gea Beunders (G)

Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.

Anne-Marie Bisgaard (AM)

Center for Rett syndrome, Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Denmark.

V A Bjerregaard (VA)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Ange-Line Bruel (AL)

INSERM UMR1231, GAD, University of Burgundy, FHU-TRANSLAD, CHU Dijon-Bourgogne, Dijon, France.

Thomas D Challman (TD)

Geisinger Autism & Developmental Medicine Institute, Lewisburg, PA, USA.

Benjamin Cogné (B)

Service de Génétique Médicale, CHU Nantes, Nantes, France.
Université de Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Christine Coubes (C)

Département de Génétique Médicale, Maladies rares et Médecine personnalisée, CHU Montpellier, France.

Stella A de Man (SA)

Department of Pediatrics, Amphia Hospital, Breda, The Netherlands.

Anne-Sophie Denommé-Pichon (AS)

INSERM UMR1231, GAD, University of Burgundy, FHU-TRANSLAD, CHU Dijon-Bourgogne, Dijon, France.

Thomas J Dye (TJ)

Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Frances Elmslie (F)

South West Thames Regional Genetics Service, St George's University Hospitals, University of London, London, United Kingdom.

Lars Feuk (L)

Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Sixto García-Miñaúr (S)

Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.

Tracy Gertler (T)

Division of Neurology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Elisa Giorgio (E)

Department of Medical Sciences, University of Turin, Torino, Italy.

Nicolas Gruchy (N)

Service de Génétique, CHU Caen Clemenceau, Biotargen, Univ Caen, France.

Tobias B Haack (TB)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Chad R Haldeman-Englert (CR)

Mission Fullerton Genetics Center, Asheville, NC, USA.

Bjørn Ivar Haukanes (BI)

Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Juliane Hoyer (J)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Anna C E Hurst (ACE)

Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.

Bertrand Isidor (B)

Service de Génétique Médicale, CHU Nantes, Nantes, France.
Université de Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Maria Johansson Soller (MJ)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Sulagna Kushary (S)

Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Malin Kvarnung (M)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Yuval E Landau (YE)

Leumit Health Care Services, Tel-Aviv, Israel.
Metabolic Disease Service, Schneider Children's Medical Center of Israel, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Kathleen A Leppig (KA)

Genetic Services, Kaiser Permanente of Washington, Seattle, WA, USA.

Anna Lindstrand (A)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Lotte Kleinendorst (L)

Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Alex MacKenzie (A)

Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.

Giorgia Mandrile (G)

Thalassemia Centre and Genetic Unit, San Luigi University Hospital, Orbassano, Italy.

Bryce A Mendelsohn (BA)

Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, CA, USA.

Setareh Moghadasi (S)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Jenny E Morton (JE)

West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's Hospitals NHS Foundation Trust, Birmingham Women's Hospital, Birmingham, United Kingdom.

Sebastien Moutton (S)

INSERM UMR1231, GAD, University of Burgundy, FHU-TRANSLAD, CHU Dijon-Bourgogne, Dijon, France.
CPDPN, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence, France.

Amelie J Müller (AJ)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Melanie O'Leary (M)

Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Marta Pacio-Míguez (M)

Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.

Maria Palomares-Bralo (M)

Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.

Sumit Parikh (S)

Mitochondrial Medicine & Neurogenetics, Cleveland Clinic, Cleveland, OH, USA.

Rolph Pfundt (R)

Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel.

Ben Pode-Shakked (B)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel.
Wohl Institute for Translational Medicine and Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel.

Anita Rauch (A)

Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland.

Elena Repnikova (E)

Division of Clinical Laboratory Genetics & Genomics, Children's Mercy Hospital, Kansas City, MO, USA.

Anya Revah-Politi (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Precision Genomics Laboratory, Columbia University Irving Medical Center, New York, NY, USA.

Meredith J Ross (MJ)

Department of Pediatrics, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA.

Claudia A L Ruivenkamp (CAL)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Elisabeth Sarrazin (E)

Centre de Référence des Maladies rares neuromusculaires AOC, Hôpital Pierre Zobda Quitman, CHU Martinique, Fort de France, Martinique.

Juliann M Savatt (JM)

Geisinger Autism & Developmental Medicine Institute, Lewisburg, PA, USA.

Agatha Schlüter (A)

Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, and Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.

Bitten Schönewolf-Greulich (B)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Zohra Shad (Z)

Cook Children's Medical Center Genetics, Fort Worth, TX, USA.

Charles Shaw-Smith (C)

Department of Clinical Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.

Joseph T Shieh (JT)

Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.

Motti Shohat (M)

Bioinformatics unit, Cancer Research Center, Sheba Medical Center and Sackler Medical Center, Tel Aviv University and Maccabi HMO, Tel Aviv, Israel.

Stephanie Spranger (S)

Praxis fuer Humangenetik, Klinikum Bremen-Mitte, Bremen, Germany.

Heidi Thiese (H)

Genetic Services, Kaiser Permanente of Washington, Seattle, WA, USA.

Frederic Tran Mau-Them (FT)

INSERM UMR1231, GAD, University of Burgundy, FHU-TRANSLAD, CHU Dijon-Bourgogne, Dijon, France.

Bregje van Bon (B)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Ineke van de Burgt (I)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Ingrid M B H van de Laar (IMBH)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Esmée van Drie (E)

Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Mieke M van Haelst (MM)

Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Conny M van Ravenswaaij-Arts (CM)

Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.

Edgard Verdura (E)

Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, and Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.

Antonio Vitobello (A)

INSERM UMR1231, GAD, University of Burgundy, FHU-TRANSLAD, CHU Dijon-Bourgogne, Dijon, France.

Stephan Waldmüller (S)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Sharon Whiting (S)

Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Carlos E Prada (CE)

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Bert B A de Vries (BBA)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

William B Dobyns (WB)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Department of Pediatrics, University of Washington, Seattle, WA, USA.
Department of Neurology, University of Washington, Seattle, WA, USA.

Simone F Reiter (SF)

Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Paulino Gómez-Puertas (P)

Molecular Modelling Group, Severo Ochoa Molecular Biology Centre (CBM SO, CSIC-UAM), Madrid, Spain.

Aurora Pujol (A)

Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, and Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain.
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.

Zeynep Tümer (Z)

Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Zeynep.tumer@regionh.dk.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Zeynep.tumer@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH